Chronic Pain MedsCheck Trial


The Chronic Pain MedsCheck Trial has now ended. Thank you to all of our participants, we appreciate your contribution to this important research trial.


Patient Consent Forms

Patient Consent Forms

Thank you to everyone who has sent their patient consent forms to our research partners, HealthConsult.

Yet to send your forms? Now is the time – all main and evaluation site patient consent forms should be returned to HealthConsult using the prepaid envelopes your pharmacy received in December 2019.

Need more envelopes? No problem, just give us a call.

The Trial

The Chronic Pain MedsCheck Trial is funded by the Australian Department of Health as part of the Sixth Community Pharmacy Agreement (6CPA) Pharmacy Trial Program (PTP).

The 6CPA PTP was established to trial new and expanded Community Pharmacy Programs that seek to improve clinical outcomes for consumers and by progressing the role of community pharmacies in the delivery of primary healthcare services.

The Chronic Pain MedsCheck Trial objective is to evaluate the efficacy of the Chronic Pain MedsCheck service in:

  • preventing incorrect use and/or overuse of pain medication,
  • increasing patients’ pain medication health literacy,
  • improving their ability to self-manage their chronic pain, and;
  • improving their overall quality of life


Community pharmacy registrations for the Chronic Pain MedsCheck Trial are now closed.


You can find the resources that were developed for this trial along the right hand side this page.

Patient Services

The Chronic Pain MedsCheck Trial is a Pharmacy Trial Program (PTP) trialling the delivery of a specialised Chronic Pain MedsCheck within community pharmacy.

The trial intervention from community pharmacy includes:

  • supported self -management of patients taking medication who are dealing with chronic pain for more than three months through pharmacist advice;
  • pharmacy-based evaluation of patient’s medicine, and;
  • provision of an action plan
    • action plans incorporated education, self-management and referral to other health professionals where additional support is required.
  • three month follow up after the initial service

The Chronic Pain MedsCheck trial includes two randomly selected intervention groups, Group A and Group B:

Group A: Involves an initial in-pharmacy face-to-face consultation between the pharmacist and the consumer and a three month follow up consultation.

Group B: Involves an initial in-pharmacy face-to-face consultation between the pharmacist and the consumer; a six week midpoint follow up consultation by telephone, and a three month follow up consultation.

From each group are also randomly selected a number of evaluation pharmacies, to provide additional information on the intervention. These pharmacies were provided appropriate remuneration for the additional request of their time. Please see the Pharmacy/Pharmacist Information Statement for more details.

The Chronic Pain MedsCheck Trial service includes the provision of information about accessing additional support, or where appropriate a referral to the patients’ GP or allied health professional.

Community pharmacies delivering Chronic Pain MedsChecks are encouraged to build relationships with other health professionals providing support for patients with chronic pain.

For more detail about the service, please read the Pharmacy/Pharmacist Information Statement.

Claims and Payments

The Chronic Pain MedsCheck Trial uses a passive claiming system. This means as long as you have completed all the required data correctly in the GuildcareNG software, you will be paid for services after data validation. There is no requirement to submit a claim for payment.

If any further information is required for payment, the project team will contact you.


You can call the Guild Trial Programs on 1300 555 262 or email for any further queries.